Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Oct;37(10):13489-13498.
doi: 10.1007/s13277-016-5192-x. Epub 2016 Jul 27.

High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer

Affiliations
Free article
Comparative Study

High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer

Xiuli Chen et al. Tumour Biol. 2016 Oct.
Free article

Abstract

Rad51c is critical for homologous recombination repair and genomic stability and may play roles in tumorigenesis and cancer therapy. We investigated the expression level and clinical significance of Rad51c in non-small cell lung cancer (NSCLC) and determined the effect of Rad51c on NSCLC cell chemosensitivity and radiosensitivity. Rad51c expression was detected using immunohistochemistry and was higher in NSCLC patient samples than in adjacent normal tissues. Kaplan-Meier analysis revealed that high Rad51c expression was an independent predictor of short overall survival (OS) and disease-free survival (DFS) in NSCLC patients receiving chemotherapy and/or radiotherapy. Furthermore, Rad51c knockdown increased the killing effect of ionizing radiation (IR) and enhanced cisplatin-induced apoptotic cells in NSCLC cells by disrupting the repair of cisplatin- and IR-induced DNA damage. In addition, ectopic expression of Rad51c dramatically enhanced NSCLC cell resistance to cisplatin and radiotherapy. These findings suggest that increased expression of Rad51c may confer resistance to chemotherapy and/or radiotherapy of NSCLC, and also be an independent prognostic factor for patient outcome. Therefore, targeting Rad51c may represent an improved therapeutic strategy for NSCLC patients with locally advanced disease.

Keywords: Chemotherapy; DNA damage repair; Non-small cell lung cancer; Prognosis; Rad51c; Radiotherapy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Oncol. 2013 Mar 10;31(8):1029-38 - PubMed
    1. Nat Genet. 2010 May;42(5):406-9 - PubMed
    1. Nat Genet. 2010 May;42(5):410-4 - PubMed
    1. Oncotarget. 2015 Apr 20;6(11):8777-87 - PubMed
    1. J Cell Biol. 2009 May 18;185(4):587-600 - PubMed

Publication types

MeSH terms

LinkOut - more resources